Tuvalu Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Health Digest.

Press releases published on September 3, 2026

Sep. 3, 2026

Ondra Health Expands to Six Named GLP-1 Pharmacy Partners, Giving Patients More Choice

Indeterminate GlobeNewswire

Sep. 3, 2026

Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow

Indeterminate GlobeNewswire

Sep. 3, 2026

InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Priothera Appoints Experienced Biotech Executive, Dr Nigel Clark, as Chief Business Officer to Lead Strategic Partnering for Mocravimod

Indeterminate GlobeNewswire

Sep. 3, 2026

Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Quince Therapeutics to Participate in September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Biomea Fusion to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Vivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and Technology

Indeterminate GlobeNewswire

Sep. 3, 2026

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

Indeterminate GlobeNewswire

Sep. 3, 2026

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

Indeterminate GlobeNewswire

Sep. 3, 2026

Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Trevi Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting

Indeterminate GlobeNewswire

Sep. 3, 2026

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

Indeterminate GlobeNewswire

Sep. 3, 2026

Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 3, 2026

Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York

Indeterminate GlobeNewswire